Search results for "rigaku"
Selected Filters:
Fluoxetine (Prozac)
Purine nucleotides analyzed with HPLC
Water soluble vitamin tablet analysis with HPLC
The MEA2 System in action
Independent market research says 84% of US Healthcare professionals likely to use Orviglance in target population
Research confirms the unmet need for an effective alternative to unenhanced MRI and a safe alternative to GBCAs
Beckman Coulter achieves CE Mark for its MDW-SARS CoV-2 application as an aid in identifying patients with risk of COVID-19
The MDW-SARS CoV-2 application has shown to aid A&E patients
Waters introduces a reliable and automated solution for mass and purity analysis of biomolecules
New Intact Mass software application on waters_connect enables simplified and significantly faster analysis of biomolecules for mass and purity
Isobaric metabolites in urine analyzed with LCMS
Milk extract analyzed by LCMS
Domoic acid & amino acids in algae extracts analyzed with LCMS
Harnessing the power of label-free molecular interaction analysis in biopharmaceutical characterization
Dr. Kalhari Silva, the Head of Scientific Innovation and Research at Custom Biologics, shares how her organization is able to offer a complete package of bioanalytical testing services that are compliant with evolving regulatory requirements
3D Cell Culture: Tumor-specific cancer treatments, organoid quality, drug screening and more
Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications
5 upcoming webinars to supplement your scientific research
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on food testing, neurodevelopment, protein stability, data integrity, and more
Master multiplex assay design for drug discovery
Everything you need to know when choosing a multiplex immunoassay for your drug discovery program
Taq Pro Universal SYBR qPCR Master Mix
Characterizing vaccines with the light scattering toolkit
Sample preparation: Digestion at its best
Discovery in bone marrow cancer points to potential drug targets
Research finds patients with ASXL1 have distinctive epigentic changes that can activate harmful genes